secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001193125-25-241591
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

C4 Therapeutics raises $117M net in underwritten offering of stock and warrants
-------------------------------------------------------------------------------

- Offering includes 21.9M shares, pre-funded warrants for 28.7M shares, and Class A/B warrants for 50.6M shares each.
- Combined price per unit $2.47; net proceeds ~$117M, extending cash runway to end of 2028.
- If all warrants cash exercised, total net proceeds could reach $341.7M.
- Class A warrants expire on earlier of 30 days post Phase 1b data or 5 years; Class B warrants mandatory if stock >$6.66.
- Pre-funded warrants have $0.0001 exercise price and no expiration; all warrants subject to beneficial ownership limits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000119312525241591/0001193125-25-241591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000119312525241591/d19436d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-241591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer